Radiolife signed last Friday (29/01), a term of partnership with the State Department of Health of Espírito Santo (Sesa), through the Institute of Education, Research and Innovation (ICEPi).
According to the commitment, the objective is to carry out final calibration tests of the Cube Scan, equipment under development in the company for diagnosis of the new Coronavirus (Sars-Cov-2).
Partnership with Sesa
The solemnity of signing the document took place at the headquarters of Sesa, in Vitória. From Radiolife, were present the electrical engineer and co-founder Willians Dias and the legal representative Jean Magno. Sesa was represented by the state secretary of health, Nesio Fernandes, the director-general of ICEPi, Daniel Henrique Rezende and the director of Lacen, Rodrigo Rodrigues. From this commitment, RadioLife will provide the equipment and staff to operate it within Sesa. The goal is to finalize the clinical tests with samples of the virus that causes covid-19.
The test period covers the next 30 days and may be extended for an equal period. "This partnership is essential for the final accreditation of the Cube Scan. It has already been tested and calibrated in other opportunities, presenting great success rates," highlight the owners of Radiolife.
Based on radiofrequency technology, covid-19's diagnostic solution provides results in 10 seconds and does not require the use of reagents. The idea arose from the observation of the difficulties related to rapid and orthomolecular tests, such as price, processing capacity and collection date.
The equipment has already been tested successfully in national laboratories. Now, it begins the final phase of testing at Sesa. In parallel, the company seeks authorizations from the National Health Surveillance Agency (Anvisa) to market the device. Learn more about Cube Scan here.
Radiolife is a technology and innovation company in the area of treatment and diagnosis. Radiolife is a startup incorporated in Delaware, with presence also in Silicon Valley, where it carries out research and development activities. Prior to the Covid-19 pandemic, it already had patented solutions for healthcare. Among them, a technology for cancer diagnosis and treatment. This patent and the Cube Scan are based on radio frequency technology.
Questions? Comments? Concerns? Contact us for more information. We'll quickly get back to you with the information you need.